This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Can exercise benefits be harnessed with drugs? A new way to combat neurodegenerative diseases by boosting neurogenesis
Translational Neurodegeneration Open Access 25 July 2024
-
Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option
Molecular Diagnosis & Therapy Open Access 12 May 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original articles
Ravanidis, S. et al. Circulating brain-enriched microRNAs for detection and discrimination of idiopathic and genetic Parkinson’s disease. Mov. Disord. https://doi.org/10.1002/mds.27928 (2019)
Cressatti, M. et al. Salivary microR-153 and microR-223 levels as potential diagnostic biomarkers of idiopathic Parkinson’s disease. Mov. Disord. https://doi.org/10.1002/mds.27935 (2019)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fyfe, I. MicroRNAs — diagnostic markers in Parkinson disease?. Nat Rev Neurol 16, 65 (2020). https://doi.org/10.1038/s41582-019-0305-y
Published:
Issue date:
DOI: https://doi.org/10.1038/s41582-019-0305-y
This article is cited by
-
Can exercise benefits be harnessed with drugs? A new way to combat neurodegenerative diseases by boosting neurogenesis
Translational Neurodegeneration (2024)
-
Unraveling Dysregulated Cell Signaling Pathways, Genetic and Epigenetic Mysteries of Parkinson’s Disease
Molecular Neurobiology (2024)
-
Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option
Molecular Diagnosis & Therapy (2022)
-
Diagnostic Performance of miR-485-3p in Patients with Parkinson’s Disease and its Relationship with Neuroinflammation
NeuroMolecular Medicine (2022)